RFX1 and colonic neoplasm: Collectively, these findings raise the hypothesis that RFX1 acts as an oncogenic transcription factor in colon cancer by shaping an immunosuppressive microenvironment, modulating mutational dynamics, and conferring resistance to immunotherapy.